KYTEUVIA Trademark

Trademark Overview


On Monday, March 14, 2016, a trademark application was filed for KYTEUVIA with the United States Patent and Trademark Office. The USPTO has given the KYTEUVIA trademark a serial number of 86939190. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 17, 2023. This trademark is owned by GW Research Limited. The KYTEUVIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical preparations and substances for the treatment of Dravet syndrome, hypoxic-ischaemic encephalopathy, Lennox-Gastaut syndrome (LGS), tuberous scle...
kyteuvia

General Information


Serial Number86939190
Word MarkKYTEUVIA
Filing DateMonday, March 14, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 17, 2023
Registration Number5194185
Registration DateTuesday, May 2, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 14, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical preparations and substances for the treatment of Dravet syndrome, hypoxic-ischaemic encephalopathy, Lennox-Gastaut syndrome (LGS), tuberous sclerosis syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15q infantile spasms, and Doose syndrome; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's, bone disorders, hypoxic-ischaemic encephalopathy, drug, alcohol and nicotine abuse and inflammatory disorders; pure extracts of medicinal plants and herbs used for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's, hypoxic-ischaemic encephalopathy, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders; herb teas for medicinal purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGW Research Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge CB249BZ
GB

Party NameGW Research Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge CB249BZ
GB

Party NameGW Research Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge CB249BZ
GB

Trademark Events


Event DateEvent Description
Friday, November 17, 2023CANCELLED SEC. 8 (6-YR)
Monday, May 2, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, September 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 28, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, November 29, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 29, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 2, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, February 14, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 14, 2017PUBLISHED FOR OPPOSITION
Wednesday, January 25, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 10, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 4, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 4, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, January 4, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 4, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, January 4, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, December 22, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 22, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 17, 2016ASSIGNED TO LIE
Sunday, December 4, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 24, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 24, 2016NON-FINAL ACTION E-MAILED
Friday, June 24, 2016NON-FINAL ACTION WRITTEN
Friday, June 24, 2016ASSIGNED TO EXAMINER
Thursday, March 17, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 17, 2016NEW APPLICATION ENTERED